FDA Warns J&J Unit Over Insulin Pump Reporting Delays
The U.S. Food and Drug Administration in a letter released Tuesday warned a Johnson & Johnson subsidiary to promptly correct its repeated failure to timely report adverse incidents related to its...To view the full article, register now.
Already a subscriber? Click here to view full article